$CUR Form 8-K

0
475
Biotech Stocks

Form 8-K for NEURALSTEM, INC.


16-Mar-2015

Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition.On March 16, 2015, Neuralstem, Inc. (the “Company”) reported fiscal 2014 fourth quarter and year-end business results for the year ended December 31, 2014 and provided an update on clinical programs and business highlights. The press release is attached as Exhibit 99.01 and is incorporated herein by reference.

The information furnished under Items 2.02, including the accompanying Exhibit 99.01 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of such section, nor shall such information be deemed to be incorporated by reference in any subsequent filing by the Company under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as specifically stated in such filing.

LEAVE A REPLY

Please enter your comment!
Please enter your name here